S'abonner

Evidence and Consensus-based Imaging Guidelines in Birdshot Chorioretinopathy: Multimodal Imaging in Uveitis (MUV) Taskforce Report 8 - 13/09/25

Doi : 10.1016/j.ajo.2025.06.029 
FRANCESCO PICHI 1, 2, ⁎ , ELISABETTA MISEROCCHI 3, 4, DILRAJ S. GREWAL 5, SUMIT SHARMA 6, ANTOINE P. BRÉZIN 7, BAHRAM BODAGHI 8, ANIRUDDHA AGARWAL 1, 2, DOUGLAS A. JABS 9, 10, AMANI FAWZI 11, DAVID SARRAF 12, VISHALI GUPTA 13, ⁎

ON BEHALF OF THE MULTIMODAL IMAGING IN UVEITIS (MUV) TASKFORCE⁎

  Full list of task force members in Appendix I
Alejandra de-la-Torre 14, Alejandro Fonollosa 15, Alessandro Invernizzi 16, 17, Amani Fawzi 18, Andrew Dick 19, 20, 21, 22, Aniruddha Agarwal 23, 24, Anita Agarwal 25, 26, Antoine Brezin 27, Ariel Schlaen 28, Bahram Bodaghi 29, Claudia Fabiani 30, David Sarraf 31, Debra A. Goldstein 32, Dilraj Grewal 33, Edmund Tsui 34, Elisabetta Miserocchi 35, 36, Ester Carreño 37, Francesco Pichi 23, Ilknur Tugal-Tutkun 38, Inês Leal 39, Janet L. Davis 40, Jeanette Ossewaarde-van Norel 41, Jennifer E. Thorne 42, Jessica G. Shantha 43, Jose S. Pulido 44, Justine Smith 45, Jyotirmay Biswas 46, K. Bailey Freund 47, 48, Kathryn Pepple 49, Lee M. Jampol 32, Luca Cimino 50, 51, Marc De Smet 52, Maria Vittoria Cicinelli 36, Marion R. Munk 53, Massimo Accorinti 54, Maura Di Nicola 55, Meghan Berkenstock 42, Michael Altaweel 56, 57, Phoebe Lin 58, Quan Dong Nguyen 59, Richard Spaide 47, Rupesh Agrawal 60, 61, 62, Sapna S. Gangaputra 63, Soon Phaik Chee 64, Srinivas Sadda 65, Sumit Sharma 66, Timothy M. Janetos 32, Vishali Gupta 67, Zohar Habot-Wilner 68
14 Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia 
15 Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain 
16 Eye Clinic, Department of Biomedical and Clinical Science, Luigi Sacco Hospital, University of Milan, Milan, Italy 
17 Department of Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia 
18 Northwestern University Feinberg School of Medicine, Chicago, USA 
19 University of Bristol, UK 
20 Bristol Eye Hospital, UK 
21 Institute of Ophthalmology, University College London, London, UK 
22 National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, UK 
23 Eye Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates 
24 Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA 
25 California Pacific Medical Center (CPMC), San Francisco, CA, USA 
26 West Coast Retina, San Francisco, CA, USA 
27 Department of Ophthalmology, Ophtalmopôle, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, AP-HP, Université Paris Cité, 75014, Paris, France 
28 Hospital Universitario Austral, Derqui-Pilar, Argentina 
29 Department of Ophthalmology, IHU FOReSIGHT, Pitié-Salpêtrière Universtiy Hospital, Paris, France 
30 Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena and Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory, and Autoimmune Diseases (RITA) Center], Sienna, Italy 
31 Stein Eye Institute, University of California, Los Angeles, California, USA 
32 Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois USA 
33 Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA 
34 Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 
35 School of Medicine, Vita-Salute San Raffaele University, Milan, Italy 
36 Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy 
37 Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain 
38 Department of Ophthalmology, Istanbul University, Istanbul, Turkey 
39 Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa (CAML), Lisbon, Portugal 
40 Department of Ophthalmology, University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, Miami, FL, USA 
41 University Medical Center Utrecht, Utrecht, the Netherlands 
42 Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
43 Francis I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, USA 
44 Wills Eye Hospital, Thomas Jefferson University Philadelphia, PA 
45 College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia 
46 Uveitis & Ocular Pathology Department, Sankara Nethralaya, Chennai, India 
47 Vitreous Retina Macula Consultants of New York, New York, USA 
48 Department of Ophthalmology, NYU Grossman School of Medicine, New York, NY, USA 
49 Department of Ophthalmology, University of Washington, Seattle, USA 
50 Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy 
51 Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy 
52 Micro Invasive Ocular Surgery Clinic, Lausanne, Switzerland 
53 Augenarzt Praxisgemeinschaft Gutblick, Pfäffikon, Switzerland 
54 IRCSS Fondazione Bietti, Rome, Italy 
55 Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA 
56 Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA 
57 McPherson Eye Research Institute, University of Wisconsin - Madison, WI, USA 
58 Cleveland  Clinic Foundation, Cole Eye Institute, Cleveland, USA 
59 Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA 
60 National Healthcare Group Eye institute, Tan Tock Seng Hospital, Singapore 
61 LKC School of Medicine, Nanyang Technological University, Singapore 
62 Duke NUS Medical School, Singapore 
63 Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, USA 
64 Department of Ocular Inflammation and Immunology, Singapore National Eye Centre, Singapore 
65 Doheny Eye Institute, University of California – Los Angeles, Los Angeles, California, USA 
66 Cleveland Clinic Foundation, Cole Eye Institute, Cleveland, USA 
67 Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India 
68 Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel 

1 From the Cleveland Clinic Abu Dhabi (F.P., A.A.), Eye Institute, Abu Dhabi, United Arab Emirates 
2 Cleveland Clinic Lerner College of Medicine (F.P, A.A.), Case Western Reserve University, Cleveland, Ohio, USA 
3 School of Medicine (E.M.), Vita-Salute San Raffaele University, Milan, Italy 
4 Department of Ophthalmology (E.M.), IRCCS San Raffaele Scientific Institute, Milan, Italy 
5 Department of Ophthalmology (D.G.), Duke University School of Medicine, Durham, North Carolina, USA 
6 Cleveland Clinic Foundation (S.S.), Cole Eye Institute, Cleveland, Ohio USA 
7 Centre d’ophtalmologie de l’Assistance Publique – Hôpitaux de Paris (A.B.), Université Paris Cité, Paris, France 
8 Department of Ophthalmology (B.B), Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France 
9 Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology (D.J), The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA 
10 Department of Ophthalmology (D.J.), Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
11 Department of Ophthalmology (A.F), Northwestern University Feinberg School of Medicine, Chicago, Illinois USA 
12 Stein Eye Institute (D.S), University of California, Los Angeles, California, USA 
13 Advanced Eye Centre (V.G.), Postgraduate Institute of Medical Education and Research, Chandigarh, India 

⁎Inquiries to Vishali Gupta, Advanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, IndiaAdvanced Eye Center, Post Graduate Institute of Medical Education and Research (PGIMER)ChandigarhIndia⁎⁎Inquiries to Francesco Pichi, Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab EmiratesEye Institute, Cleveland Clinic Abu DhabiAbu DhabiUnited Arab Emirates

Résumé

Purpose

To develop consensus-based imaging guidelines for diagnosing and monitoring birdshot chorioretinopathy (BSCR).

Design

Consensus-based approach guided by literature and an expert committee using a nominal group technique (NGT).

Methods

An expert committee of 5 international uveitis specialists reviewed 15 well-documented representative BSCR cases with comprehensive imaging data. Cases with active and inactive disease were included. Imaging, including color fundus photography (CFP), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), fundus autofluorescence (FAF), and OCT angiography (OCTA) were reviewed. Using a structured NGT approach, consensus-based recommendations were developed for specific disease characteristics, biomarkers of activity, and complications. The recommendations were voted upon by members of the full task force.

Results

For the diagnosis of BSCR, CFP, FFA, and ICGA were identified as the key imaging modalities. ICGA was identified as a key imaging modality for assessing the presence of choroidal lesions. FFA was deemed crucial for monitoring retinal vascular leakage and assessing the treatment response. OCT, while not essential for diagnosis, was valuable for detecting complications such as cystoid macular edema and retinal thinning. The committee did not reach a consensus on the role of FAF and OCTA for the diagnosis or monitoring of BSCR.

Conclusions

The MUV consensus-based imaging guidelines for BSCR expand the Standardization of Uveitis Nomenclature (SUN) classification criteria by reaffirming the critical role of ICGA and providing a standardized guidelines for using other imaging modalities in the diagnosis and monitoring of BSCR. These guidelines are expected to facilitate monitoring of disease activity and complications using multimodal imaging.

Le texte complet de cet article est disponible en PDF.

Plan


 This invited article was submitted as part of the Virtual Special Issue on Multimodal Imaging in Uveitis.


© 2025  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 278

P. 271-281 - octobre 2025 Retour au numéro
Article précédent Article précédent
  • Evidence and Consensus-Based Imaging Guidelines in Noninfectious Posterior Uveitis—Methodology of the Multimodal Imaging in Uveitis (MUV) Project Report 2
  • Vishali Gupta, Janet L Davis, Sapna Gangaputra, Soon P Chee, Jennifer E Thorne, Rupesh Agrawal, Alessandro Invernizzi, Aniruddha Agarwal, Marc D de Smet, David Sarraf, Douglas A Jabs, Multimodal Imaging in Uveitis (MUV) Taskforce
| Article suivant Article suivant
  • TFOS DEWS III Editorial
  • Victor L. Perez, Wei Chen, Jennifer P. Craig, Murat Dogru, Lyndon Jones, Fiona Stapleton, James S. Wolffsohn, David A. Sullivan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.